Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.00
Bid: 5.75
Ask: 6.10
Change: -0.20 (-3.27%)
Spread: 0.35 (6.087%)
Open: 6.00
High: 6.00
Low: 6.00
Prev. Close: 6.125
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Placing and Subscription

18 Mar 2021 13:57

RNS Number : 7602S
Plant Health Care PLC
18 March 2021
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

18 March 2021

Plant Health Care plc

("Plant Health Care", or the "Company")

Results of Placing and Subscription

Plant Health Care plc, a leading provider of novel patent-protected biological products to global agricultural markets, today announces that, further to its announcement at 7.00 a.m. today (the "Placing Announcement"), it has successfully completed the Fundraising which is now closed.

The Placing and Subscription has raised approximately $10.0 million (before expenses) through the placing of 50,397,913 new Ordinary Shares of £0.01 each ("Ordinary Shares") with investors at an Issue Price of 14 pence per share. The Fundraising was substantially over-subscribed.

Capitalised terms used in this announcement (this "Announcement") have the meanings given to them in the Placing Announcement, unless the context provides otherwise.

Director participation

The following Directors of the Company participated in the Fundraising:

Name of Director

Number of Placing Shares subscribed for

Number of Subscription Shares subscribed for

Total Ordinary Shares following the Fundraising

Total interest in the enlarged issued share capital

Christopher Richards

392,000

-

2,975,015

1.0%

Richard Webb

35,714

-

1,300,978

0.4%

Jeff Hovey

-

15,347

44,423

Jeff Tweedy

-

12,789

79,153

 

Subscription

Under the Subscription, the Company has raised approximately US$0.7 million (before expenses) conditional upon Admission of the Subscription Shares by way of the subscription at the Issue Price of 3,634,863 Subscription Shares.

Admission

Completion of the Placing and Subscription remains subject, inter alia, to Admission of the Placing Shares and Subscription Shares. It is expected that dealings in the Placing Shares and Subscription Shares will commence at 8.00 a.m. on 24 March 2021 (or such time and/or date as the Company and the Joint Brokers may agree, being not later than 30 April 2021).

Total voting rights

Following Admission of the Placing Shares and Subscription Shares, the Company will have a total of 302,387,482 Ordinary Shares in issue. With effect from Admission of the Placing Shares and Subscription Shares, this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure Guidance and Transparency Rules of the FCA.

For further information, please contact:

Plant Health Care plc

Tel: +1 919 926 1600

Chris Richards, CEO

Arden Partners plc - Nomad & Joint Broker

Tel: +44 (0) 20 7614 5900

John Llewellyn-Lloyd / Benjamin Cryer

Cenkos Securities plc - Joint Broker

Tel: +44 (0) 20 7391 8900

Neil McDonald / Peter Lynch

 

PDMR Notification Form

The notification below is made in accordance with the requirements of MAR.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

a) Christopher Richards

b) Richard Webb

c) Jeffrey Hovey

d) Jeffrey Tweedy

2

Reason for the notification

a)

Position/status

a) Chief Executive Officer

b) Non-Executive Chairman

c) Chief Financial Officer

d) Chief Operating Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Plant Health Care plc

b)

LEI

213800KBQPJZ2FM8QH27

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

 

 

 

 

GB00B01JC540

b)

Nature of the transaction

Participation in placing and subscription

c)

Price(s) and volume(s)

Price - 14p

Volumes:

a) 392,000

b) 35,714

c) 15,347

d) 12,789

d)

Aggregated information

See 4c) above

e)

Date of the transaction

18 March 2021

f)

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEDKFBPNBKDQND
Date   Source Headline
2nd Apr 20095:47 pmRNSMonsanto Order
1st Apr 20093:40 pmRNSAdditional Listing
30th Mar 20097:00 amRNSDirector/PDMR Shareholding
24th Mar 200910:49 amRNSChange of Registered Office
24th Mar 20097:00 amRNSFinal Results
2nd Mar 200910:06 amRNSTotal Voting Rights
2nd Feb 200912:53 pmRNSTotal Voting Rights
2nd Feb 200911:01 amRNSBoard Appointment
28th Jan 20094:36 pmRNSPrice Monitoring Extension
28th Jan 20097:00 amRNSAdditional Listing
22nd Jan 20097:00 amRNSTrading Statement
15th Jan 20097:00 amRNSNew Appointments
5th Jan 20099:57 amRNSSignificant Shareholding
31st Dec 200811:19 amRNSTotal Voting Rights
19th Dec 20084:22 pmRNSHolding(s) in Company
18th Dec 20087:01 amRNSFurther re Myconate
18th Dec 20087:00 amRNSTermination of Agreement
16th Dec 20087:00 amRNSFinal Agreement with Monsanto
1st Dec 200810:02 amRNSTotal Voting Rights
26th Nov 20087:00 amRNSField Trials
18th Nov 200812:21 pmRNSAdditional Listing
31st Oct 20083:35 pmRNSTotal Voting Rights
30th Oct 20084:01 pmRNSBoard Appointment
20th Oct 200811:26 amRNSHolding(s) in Company
8th Oct 20081:05 pmRNSSignificant shareholding
2nd Oct 20087:52 amRNSField Trials
30th Sep 20088:00 amRNSTotal Voting Rights
25th Sep 20087:00 amRNSRe Scotts agreement
23rd Sep 20087:00 amRNSPreTect Field Trial Results
17th Sep 20087:00 amRNSAgreement with Bayer CropScience
15th Sep 20082:06 pmRNSPosting of Interim Results
9th Sep 20084:32 pmRNSDirector/PDMR Shareholding
8th Sep 20087:01 amRNSSupply Agreement
8th Sep 20087:00 amRNSInterim Results
1st Sep 200810:03 amRNSTotal Voting Rights
29th Aug 200810:37 amRNSNotice of Results
15th Aug 200812:36 pmRNSHolding(s) in Company
1st Aug 20081:08 pmRNSTotal Voting Rights
7th Jul 200812:21 pmRNSHolding(s) in Company
4th Jul 20087:00 amRNSProduct Update
3rd Jul 20087:00 amRNSCleantech Index
2nd Jul 200812:07 pmRNSStock Award
1st Jul 200811:49 amRNSTotal Voting Rights
17th Jun 20085:36 pmRNSAdditional Listing
17th Jun 20083:47 pmRNSNotification of Shareholding
13th Jun 20082:07 pmRNSHolding(s) in Company
12th Jun 20087:00 amRNSField Trials
6th Jun 200812:59 pmRNSResult of Annual General Meet
6th Jun 20087:00 amRNSAGM Statement and Trading Upd
3rd Jun 20087:30 amRNSField Trials

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.